MX9801903A - Formulacion farmaceutica. - Google Patents

Formulacion farmaceutica.

Info

Publication number
MX9801903A
MX9801903A MX9801903A MX9801903A MX9801903A MX 9801903 A MX9801903 A MX 9801903A MX 9801903 A MX9801903 A MX 9801903A MX 9801903 A MX9801903 A MX 9801903A MX 9801903 A MX9801903 A MX 9801903A
Authority
MX
Mexico
Prior art keywords
pharmaceutical formulation
emperic
drsp
amoxycillin
treatement
Prior art date
Application number
MX9801903A
Other languages
English (en)
Other versions
MXPA98001903A (es
Inventor
Daniel Josehp Burch
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21705455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9801903(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9801903A publication Critical patent/MX9801903A/es
Publication of MXPA98001903A publication Critical patent/MXPA98001903A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Formulaciones farmacéuticas que comprenden amoxicilina y clavulanato en una relacion de 10:1 a 20:1 se usan en el tratamiento empírico de infecciones potencialmente causadas por SPRF.
MXPA/A/1998/001903A 1995-09-07 1998-03-09 Formulacion farmaceutica MXPA98001903A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US335395P 1995-09-07 1995-09-07
US003353 1995-09-07
PCT/US1996/014554 WO1997009042A1 (en) 1995-09-07 1996-09-05 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
MX9801903A true MX9801903A (es) 1998-05-31
MXPA98001903A MXPA98001903A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
NZ318282A (en) 2000-01-28
KR19990044495A (ko) 1999-06-25
WO1997009042A1 (en) 1997-03-13
HK1015701A1 (en) 1999-10-22
CN1200672A (zh) 1998-12-02
US20010038838A1 (en) 2001-11-08
EP0862431A1 (en) 1998-09-09
DE69617036T2 (de) 2002-07-11
EP0862431A4 (en) 1999-07-07
CA2231194C (en) 2004-07-20
AR004510A1 (es) 1998-12-16
CY2359B1 (en) 2004-06-04
JPH11512398A (ja) 1999-10-26
HK1043042A1 (zh) 2002-09-06
CO4750658A1 (es) 1999-03-31
CZ299595B6 (cs) 2008-09-17
NZ337247A (en) 2001-05-25
ES2165997T3 (es) 2002-04-01
NO981008L (no) 1998-05-06
NZ337246A (en) 2000-07-28
PL325411A1 (en) 1998-07-20
NO981008D0 (no) 1998-03-06
JP3501289B2 (ja) 2004-03-02
ATE208618T1 (de) 2001-11-15
CZ68398A3 (cs) 1998-07-15
TW501926B (en) 2002-09-11
ZA967546B (en) 1998-03-06
HUP9901437A3 (en) 2000-03-28
US20010043926A1 (en) 2001-11-22
TR199800415T1 (en) 1998-05-21
EP1093812A2 (en) 2001-04-25
PT862431E (pt) 2002-04-29
US20050261267A1 (en) 2005-11-24
AU6973396A (en) 1997-03-27
HUP9901437A2 (hu) 1999-09-28
EP1147771A1 (en) 2001-10-24
EP1093812A3 (en) 2001-06-06
US6726908B2 (en) 2004-04-27
EP0862431B1 (en) 2001-11-14
CN1289084C (zh) 2006-12-13
DK0862431T3 (da) 2002-03-11
BR9610396A (pt) 1999-07-06
DE69617036D1 (de) 2001-12-20
AU711441B2 (en) 1999-10-14
NO314831B1 (no) 2003-06-02
IL123563A (en) 2002-02-10
SI0862431T1 (en) 2002-06-30
KR100495585B1 (ko) 2005-09-09
CA2231194A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
CA2231194A1 (en) Pharmaceutical formulation
HK1050992A1 (zh) 含有藥物配方的阿莫西林和克拉維酸
MY115662A (en) Novel compounds with analgesic effect
GR1003560B (el) Σκευασματα τροποποιημενης απελευθερωσης αμοξυκιλλινης και κλαβουλανικου καλιου
AP1253A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate.
WO1994027589A3 (en) Antidepressant dosage form
EP1674107B8 (en) Use of daptomycin
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
MY132705A (en) Novel compounds with analgesic effect
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
ZA941525B (en) Use of riluzole in the treatment of nero-AIDS
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
SE9201249D0 (sv) Antikonception vid primater av honkoen utan paaverkan av den menstruella cykeln
AU5739499A (en) Pharmaceutical formulation of sodium amoxycillin and potassium clavulanate
TR199900013T2 (xx) Yeni bile�ikler.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
AU7076494A (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
AU6345794A (en) Ipsapirone medicament formulation
MX9708383A (es) Composicion que comprende amoxicilina y acido clavulanico.
CA2220103A1 (en) Composition comprising amoxycillin and clavulanic acid
AU3429393A (en) Pharmaceutical pentapeptide compositions and methods of use thereof
MX9804797A (es) Nuevos compuestos con efecto analgesico.
ITMI911930A1 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.
AU2833895A (en) Topical formulation of cyclosporine

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SMITHKLINE BEECHAM PLC